Kathryn Wagner - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Chen JC, King OD, Zhang Y, Clayton NP, Spencer C, Wentworth BM, Emerson CP, Wagner KR. Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 27378237 DOI: 10.1038/mt.2016.111  0.96
2016 Choi IY, Lim H, Estrellas K, Mula J, Cohen TV, Zhang Y, Donnelly CJ, Richard JP, Kim YJ, Kim H, Kazuki Y, Oshimura M, Li HL, Hotta A, Rothstein J, ... ... Wagner KR, et al. Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model. Cell Reports. PMID 27239027 DOI: 10.1016/j.celrep.2016.05.016  0.96
2016 Tawil R, Mah JK, Baker S, Wagner KR, Ryan MM. Clinical practice considerations in facioscapulohumeral muscular dystrophy Sydney, Australia, 21 September 2015. Neuromuscular Disorders : Nmd. PMID 27185458 DOI: 10.1016/j.nmd.2016.03.007  0.96
2016 Choudhury SR, Fitzpatrick Z, Harris AF, Maitland SA, Ferreira JS, Zhang Y, Ma S, Sharma RB, Gray-Edwards HL, Johnson JA, Johnson AK, Alonso LC, Punzo C, Wagner KR, Maguire CA, et al. In vivo selection yields AAV-B1 capsid for CNS and muscle gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 27117222 DOI: 10.1038/mt.2016.84  0.96
2016 Kornegay JN, Bogan DJ, Bogan JR, Dow JL, Wang J, Fan Z, Liu N, Warsing LC, Grange RW, Ahn M, Balog-Alvarez CJ, Cotten SW, Willis MS, Brinkmeyer-Langford C, Zhu H, ... ... Wagner KR, et al. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures. Skeletal Muscle. 6: 14. PMID 27047655 DOI: 10.1186/s13395-016-0085-7  0.96
2015 McNally EM, Kaltman JR, Benson DW, Canter CE, Cripe LH, Duan D, Finder JD, Hoffman EP, Judge DP, Kertesz N, Kinnett K, Kirsch R, Metzger JM, Pearson GD, Rafael-Fortney JA, ... ... Wagner KR, et al. Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy. Circulation. 131: 1590-8. PMID 25940966 DOI: 10.1161/CIRCULATIONAHA.114.015151  0.96
2015 Heslop E, Csimma C, Straub V, McCall J, Nagaraju K, Wagner KR, Caizergues D, Korinthenberg R, Flanigan KM, Kaufmann P, McNeil E, Mendell J, Hesterlee S, Wells DJ, Bushby K, et al. The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development. Orphanet Journal of Rare Diseases. 10: 49. PMID 25902795 DOI: 10.1186/s13023-015-0258-1  0.96
2015 Cohen TV, Kollias HD, Liu N, Ward CW, Wagner KR. Genetic disruption of Smad7 impairs skeletal muscle growth and regeneration. The Journal of Physiology. 593: 2479-97. PMID 25854148 DOI: 10.1113/JP270201  0.96
2015 Leung DG, Carrino JA, Wagner KR, Jacobs MA. Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy. Muscle & Nerve. PMID 25641525 DOI: 10.1002/mus.24569  0.96
2015 Meilleur KG, Jain MS, Hynan LS, Shieh CY, Kim E, Waite M, McGuire M, Fiorini C, Glanzman AM, Main M, Rose K, Duong T, Bendixen R, Linton MM, Arveson IC, ... ... Wagner KR, et al. Results of a two-year pilot study of clinical outcome measures in collagen VI- and laminin alpha2-related congenital muscular dystrophies. Neuromuscular Disorders : Nmd. 25: 43-54. PMID 25307854 DOI: 10.1016/j.nmd.2014.09.010  0.96
2014 Robin JD, Ludlow AT, Batten K, Magdinier F, Stadler G, Wagner KR, Shay JW, Wright WE. Telomere position effect: regulation of gene expression with progressive telomere shortening over long distances. Genes & Development. 28: 2464-76. PMID 25403178 DOI: 10.1101/gad.251041.114  0.96
2014 Leung DG, Herzka DA, Thompson WR, He B, Bibat G, Tennekoon G, Russell SD, Schuleri KH, Lardo AC, Kass DA, Thompson RE, Judge DP, Wagner KR. Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy. Annals of Neurology. 76: 541-9. PMID 25042693 DOI: 10.1002/ana.24214  0.96
2014 Lamont PJ, Wallefeld W, Hilton-Jones D, Udd B, Argov Z, Barboi AC, Bonneman C, Boycott KM, Bushby K, Connolly AM, Davies N, Beggs AH, Cox GF, Dastgir J, DeChene ET, ... ... Wagner KR, et al. Novel mutations widen the phenotypic spectrum of slow skeletal/β-cardiac myosin (MYH7) distal myopathy. Human Mutation. 35: 868-79. PMID 24664454 DOI: 10.1002/humu.22553  0.96
2014 Zhang Y, King OD, Rahimov F, Jones TI, Ward CW, Kerr JP, Liu N, Emerson CP, Kunkel LM, Partridge TA, Wagner KR. Human skeletal muscle xenograft as a new preclinical model for muscle disorders. Human Molecular Genetics. 23: 3180-8. PMID 24452336 DOI: 10.1093/hmg/ddu028  0.96
2013 Donkervoort S, Schindler A, Tesi-Rocha C, Schreiber A, Leach ME, Dastgir J, Hu Y, Mankodi A, Wagner KR, Friedman NR, Bönnemann CG. 'Double trouble': diagnostic challenges in Duchenne muscular dystrophy in patients with an additional hereditary skeletal dysplasia. Neuromuscular Disorders : Nmd. 23: 955-61. PMID 24070816 DOI: 10.1016/j.nmd.2013.08.003  0.96
2013 Stadler G, Rahimov F, King OD, Chen JC, Robin JD, Wagner KR, Shay JW, Emerson CP, Wright WE. Telomere position effect regulates DUX4 in human facioscapulohumeral muscular dystrophy. Nature Structural & Molecular Biology. 20: 671-8. PMID 23644600 DOI: 10.1038/nsmb.2571  0.96
2013 Sarkozy A, Hicks D, Hudson J, Laval SH, Barresi R, Hilton-Jones D, Deschauer M, Harris E, Rufibach L, Hwang E, Bashir R, Walter MC, Krause S, van den Bergh P, Illa I, ... ... Wagner KR, et al. ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation. Human Mutation. 34: 1111-8. PMID 23606453 DOI: 10.1002/humu.22342  0.96
2013 Statland JM, McDermott MP, Heatwole C, Martens WB, Pandya S, van der Kooi EL, Kissel JT, Wagner KR, Tawil R. Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy. Neuromuscular Disorders : Nmd. 23: 306-12. PMID 23406877 DOI: 10.1016/j.nmd.2013.01.008  0.96
2012 Rahimov F, King OD, Leung DG, Bibat GM, Emerson CP, Kunkel LM, Wagner KR. Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers. Proceedings of the National Academy of Sciences of the United States of America. 109: 16234-9. PMID 22988124 DOI: 10.1073/pnas.1209508109  0.96
2012 Moyer AL, Wagner KR. Incomplete degeneration versus enhanced regeneration in skeletal muscle. The Journal of Biological Chemistry. 287: 25549; author reply . PMID 22821807 DOI: 10.1074/jbc.L112.380923  0.96
2012 Jones TI, Chen JC, Rahimov F, Homma S, Arashiro P, Beermann ML, King OD, Miller JB, Kunkel LM, Emerson CP, Wagner KR, Jones PL. Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Human Molecular Genetics. 21: 4419-30. PMID 22798623 DOI: 10.1093/hmg/dds284  0.96
2012 Greenberg SA, Salajegheh M, Judge DP, Feldman MW, Kuncl RW, Waldon Z, Steen H, Wagner KR. Etiology of limb girdle muscular dystrophy 1D/1E determined by laser capture microdissection proteomics. Annals of Neurology. 71: 141-5. PMID 22275259 DOI: 10.1002/ana.22649  0.96
2012 Kornegay JN, Childers MK, Bogan DJ, Bogan JR, Nghiem P, Wang J, Fan Z, Howard JF, Schatzberg SJ, Dow JL, Grange RW, Styner MA, Hoffman EP, Wagner KR. The paradox of muscle hypertrophy in muscular dystrophy. Physical Medicine and Rehabilitation Clinics of North America. 23: 149-72, xii. PMID 22239881 DOI: 10.1016/j.pmr.2011.11.014  0.96
2012 Homma S, Chen JC, Rahimov F, Beermann ML, Hanger K, Bibat GM, Wagner KR, Kunkel LM, Emerson CP, Miller JB. A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell function. European Journal of Human Genetics : Ejhg. 20: 404-10. PMID 22108603 DOI: 10.1038/ejhg.2011.213  0.96
2011 Moyer AL, Wagner KR. Regeneration versus fibrosis in skeletal muscle. Current Opinion in Rheumatology. 23: 568-73. PMID 21934499 DOI: 10.1097/BOR.0b013e32834bac92  0.96
2011 Judge DP, Kass DA, Thompson WR, Wagner KR. Pathophysiology and therapy of cardiac dysfunction in Duchenne muscular dystrophy. American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions. 11: 287-94. PMID 21812510 DOI: 10.2165/11594070-000000000-00000  0.96
2011 Stadler G, Chen JC, Wagner K, Robin JD, Shay JW, Emerson CP, Wright WE. Establishment of clonal myogenic cell lines from severely affected dystrophic muscles - CDK4 maintains the myogenic population. Skeletal Muscle. 1: 12. PMID 21798090 DOI: 10.1186/2044-5040-1-12  0.96
2011 Rahimov F, King OD, Warsing LC, Powell RE, Emerson CP, Kunkel LM, Wagner KR. Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor. Physiological Genomics. 43: 398-407. PMID 21266502 DOI: 10.1152/physiolgenomics.00223.2010  0.96
2011 Nazarian S, Wagner KR, Caffo BS, Tomaselli GF. Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy. Pacing and Clinical Electrophysiology : Pace. 34: 171-6. PMID 20946286 DOI: 10.1111/j.1540-8159.2010.02905.x  0.96
2010 Nazarian S, Bluemke DA, Wagner KR, Zviman MM, Turkbey E, Caffo BS, Shehata M, Edwards D, Butcher B, Calkins H, Berger RD, Halperin HR, Tomaselli GF. QRS prolongation in myotonic muscular dystrophy and diffuse fibrosis on cardiac magnetic resonance. Magnetic Resonance in Medicine. 64: 107-14. PMID 20572151 DOI: 10.1002/mrm.22417  0.96
2009 Sumner CJ, Wee CD, Warsing LC, Choe DW, Ng AS, Lutz C, Wagner KR. Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice. Human Molecular Genetics. 18: 3145-52. PMID 19477958 DOI: 10.1093/hmg/ddp253  0.96
2009 Morrison BM, Lachey JL, Warsing LC, Ting BL, Pullen AE, Underwood KW, Kumar R, Sako D, Grinberg A, Wong V, Colantuoni E, Seehra JS, Wagner KR. A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis. Experimental Neurology. 217: 258-68. PMID 19285073 DOI: 10.1016/j.expneurol.2009.02.017  0.96
2008 Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, Flanigan KM, Pestronk A, Tawil R, Wolfe GI, Eagle M, Florence JM, King WM, Pandya S, Straub V, et al. A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Annals of Neurology. 63: 561-71. PMID 18335515 DOI: 10.1002/ana.21338  0.96
2007 Wagner KR, Lechtzin N, Judge DP. Current treatment of adult Duchenne muscular dystrophy. Biochimica Et Biophysica Acta. 1772: 229-37. PMID 16887341 DOI: 10.1016/j.bbadis.2006.06.009  0.96
2006 Schiffmann R, Hauer P, Freeman B, Ries M, Scott LJ, Polydefkis M, Brady RO, McArthur JC, Wagner K. Enzyme replacement therapy and intraepidermal innervation density in Fabry disease. Muscle & Nerve. 34: 53-6. PMID 16583374 DOI: 10.1002/mus.20550  0.96
2005 Wagner KR, Liu X, Chang X, Allen RE. Muscle regeneration in the prolonged absence of myostatin. Proceedings of the National Academy of Sciences of the United States of America. 102: 2519-24. PMID 15699335 DOI: 10.1073/pnas.0408729102  0.96
1994 Wagner KR, Huganir RL. Tyrosine and serine phosphorylation of dystrophin and the 58-kDa protein in the postsynaptic membrane of Torpedo electric organ. Journal of Neurochemistry. 62: 1947-52. PMID 7512621  0.96
1993 Wagner KR, Cohen JB, Huganir RL. The 87K postsynaptic membrane protein from Torpedo is a protein-tyrosine kinase substrate homologous to dystrophin. Neuron. 10: 511-22. PMID 8461138 DOI: 10.1016/0896-6273(93)90338-R  0.96
1991 Wagner KR, Mei L, Huganir RL. Protein tyrosine kinases and phosphatases in the nervous system. Current Opinion in Neurobiology. 1: 65-73. PMID 1822293 DOI: 10.1016/0959-4388(91)90011-U  0.96
1991 Wagner K, Edson K, Heginbotham L, Post M, Huganir RL, Czernik AJ. Determination of the tyrosine phosphorylation sites of the nicotinic acetylcholine receptor. The Journal of Biological Chemistry. 266: 23784-9. PMID 1721053  0.96
Show low-probability matches.